Moreover, alternative splicing and subsequent isoform expression in three downregulated immune system genes (STMN1, MELTF, and CXCL8) had been identified that were mainly responsible for ERP progression due to suppression of the immune system and the non-recruitment of cytokines against cancer cells. This evidence concerns the gene MELTF and cancer.